Topic Hub
10 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 10 of 10 clinical reviews.
Evidence-based guide to alprostadil dosing considerations for Black and African ancestry men, covering pharmacogenomics, cardiovascular comorbidities, and titration protocols.
Read clinical reviewEvidence-based guide to alprostadil dose modifications in East Asian men, covering pharmacogenomic differences, lower starting doses, BMI thresholds, and clinical monitoring protocols.
Read clinical reviewEvidence-based guide to alprostadil dosing in South Asian men, covering pharmacogenomic factors, cardiovascular considerations, and titration protocols specific to this population.
Read clinical reviewA clinical review of alprostadil pharmacogenomics, dosing adjustments, and safety considerations specific to East Asian patients, including CYP enzyme variation, BMI thresholds, and ethnicity-stratified trial data.
Read clinical reviewA clinical deep-dive into why alprostadil responses differ in Hispanic and Latino men with erectile dysfunction, covering pharmacogenomics, diabetes burden, dosing adjustments, and ethnicity-stratified trial data.
Read clinical reviewEvidence-based guide to alprostadil dosing considerations for Hispanic and Latino patients, covering pharmacogenomic variants, diabetes-related factors, and clinical titration protocols.
Read clinical reviewA clinician-reviewed guide to alprostadil pharmacogenomics, dosing, and safety considerations specific to Hispanic and Latino patients, including CYP enzyme variants, diabetes prevalence, and ethnicity-stratified trial data.
Read clinical reviewEvidence-based review of alprostadil efficacy in East Asian men, covering pharmacogenomic factors, dose-response data, BMI-adjusted dosing, and clinical considerations for Caverject and MUSE.
Read clinical reviewSouth Asian men face unique pharmacological and cardiovascular risk factors that may affect alprostadil (Caverject/MUSE) efficacy for erectile dysfunction. This evidence-based guide covers ethnicity-stratified trial data, pharmacogenomics, dosing differences, and clinical recommendations.
Read clinical reviewEvidence-based review of how alprostadil safety, dosing, and adverse-effect patterns differ in South Asian men, including cardiovascular considerations, pharmacogenomic data, and clinical monitoring recommendations.
Read clinical review